Prostate cancer is the most common non-skin cancer in people with male anatomy. According to the American Cancer Society, almost 250,000 cases of prostate cancer are diagnosed in the U.S. each year. In fact, approximately 1 in 8 men will be diagnosed with prostate cancer during their lifetime. Many more men probably have prostate cancer but never know it.
In most cases, prostate cancer is diagnosed at an early stage. That means it hasn’t spread beyond the prostate gland. Fortunately, early-stage prostate cancers usually aren’t life-threatening. But when prostate cancer spreads to other parts of the body, it’s not curable and is often fatal. About 35,000 men die from prostate cancer in the U.S. each year.
Several factors determine how a case of prostate cancer will be monitored and treated. Some of these factors include:
Blood tests for prostate-specific antigen (PSA)
Gleason score, a measure of tumor grade
Findings on physical examination
Results of imaging tests
In this article, we’ll review how imaging tests are used in the diagnosis, treatment, and surveillance of prostate cancer.
Our Author:
David Marcus, MDDavid Marcus, MD, is a physician and medical writer. As a practicing radiation oncologist, he’s an expert in prostate cancer treatment, and he regularly treats people with prostate cancer. Dr. Marcus has published several research articles on the management of prostate cancer.
For this guide, we’ve consulted the National Comprehensive Cancer Network, the American Urologic Association, and the American College of Radiology. We’ve also referenced several recent research studies that inform the current standards of care in prostate cancer management.
Most people diagnosed with prostate cancer don’t have any symptoms. This is why screening for prostate cancer is so important. The most common way to screen for prostate cancer is with a blood test for PSA.
In general, your PSA level is considered “normal” if it’s less than 4 ng/mL. A PSA level higher than 4 ng/mL can be a sign of prostate cancer. But PSA can be elevated for other reasons, and you can have a normal PSA level and still have prostate cancer. So a PSA test alone can’t confirm prostate cancer.
If your PSA level is elevated, your healthcare provider may recommend a prostate biopsy. This involves taking a tissue sample of the prostate, usually with a needle. A biopsy is necessary to confirm a prostate cancer diagnosis in most cases.
If a prostate biopsy shows cancer, a pathologist will classify the cancer cells according to how different they look from normal cells. This is called the tumor grade, or the Gleason score. In some cases, additional tests may be done on the DNA, or genetic material, of the cancer cells.
Until recently, it was common for almost all people with elevated PSA to get a prostate biopsy. But we now know that some people with an elevated PSA don’t need a biopsy. In these situations, imaging can help make a diagnosis.
Imaging tests can also help answer questions that come up in people who have (or might have) prostate cancer. Some of these questions include:
Does this person need a prostate biopsy?
What part of the prostate gland should be biopsied?
What’s the prostate cancer stage?
What’s the best treatment for this person’s prostate cancer?
How has this person responded to prostate cancer treatment?
Has this person’s prostate cancer come back after treatment?
It’s important to note that imaging is not required in every case of prostate cancer. In many cases, treatment decisions can be made without imaging.
Several types of imaging are commonly used in the management of prostate cancer. The most common ones are:
Magnetic resonance imaging (MRI)
Trans-rectal ultrasound (TRUS)
Bone scan, or bone scintigraphy
Computed tomography (CT)
MRI scans work by using a powerful magnet to generate a three-dimensional image. A prostate MRI scan produces a clear image of the prostate gland and surrounding organs. This includes pictures of tumors within the prostate gland. MRI of the prostate gland has several different uses in people with suspected or known prostate cancer.
First, prostate MRI can help doctors decide whether someone with an elevated PSA needs a prostate biopsy. In some cases, if the PSA is elevated but the MRI looks normal, the risk of cancer may be low enough that biopsy isn’t needed.
MRI of the prostate gland can also be used in people with known prostate cancer. In these individuals, MRI can help determine the following:
Stage of the cancer
How likely it is to be aggressive
Whether it’s extending beyond the prostate gland
Best treatment plan
Getting an MRI scan involves lying flat on a table, which moves slowly through a tube. In most cases, you will get intravenous (IV) contrast dye through a vein in your arm to improve the images. Getting the IV might cause temporary discomfort, but the scan itself is painless. MRI scanners can make loud noises, and some people feel claustrophobic while they’re inside the machine. A prostate MRI usually takes about 45 to 60 minutes to complete. It’s important to know that, unlike an X-ray or a CT scan, there’s no radiation exposure with an MRI scan.
Transrectal ultrasound (TRUS) is an imaging test that is used to identify the prostate gland during a prostate biopsy.
Ultrasound works by sending out sound waves and using the echo to create an image. This mechanism is like sonar technology — often used in submarines — and the “echolocation” that dolphins and whales use to navigate in the ocean.
For prostate ultrasound, a provider will place an ultrasound probe in the rectum (hence the term “trans-rectal” ultrasound). Since the prostate sits right in front of the rectum, this produces a clear image of the prostate gland. Although the ultrasound probe causes some discomfort, most people tolerate it fairly well.
With the prostate clearly visible by ultrasound, the healthcare provider (usually a urologist) inserts the biopsy needles through the wall of the rectum into the prostate to gather tissue samples.
Prostate tumors aren’t visible on ultrasound like they are on MRI. So ultrasound and MRI are sometimes combined to biopsy a specific part of the prostate gland. This is called a fusion biopsy. To perform a fusion biopsy, ultrasound images and MRI images are “fused,” or layered on top of one another. The provider can then use a live ultrasound image to biopsy a tumor that’s only visible on MRI. Recent research shows improved detection of prostate cancer using this approach.
Bone scan, or bone scintigraphy, is an imaging test that checks the whole skeleton for metastasis, or tumor spread.
When prostate cancer spreads, it most commonly goes into bone. This is why bone scan is such a useful test in people with prostate cancer. It’s important to note that bone scan is not used in all cases of prostate cancer. In fact, it’s only used when a provider suspects or wants to rule out metastasis.
The first step in getting a bone scan is the injection of a radioactive tracer called technetium-99 into your vein. This tracer will build up in areas of bone metastasis, although it usually takes several hours to do so. So the scan isn’t done until a few hours after the injection.
The scan itself involves lying on a table while the scanner moves around the body. Like MRI and CT, bone scan is painless.
CT is an imaging test that can be used to check if a prostate cancer has spread to other areas of the body, such as lymph nodes, lungs, or liver.
CT scans work by using X-rays to generate a three-dimensional image of the body. Unlike MRI scans, CT scans use radiation.
The main advantage of CT is that it can be completed much more quickly than MRI. In addition, people experience fewer issues with claustrophobia. This is because CT scanners aren’t as narrow as MRI scanners.
There’s no single imaging test that is right for every person with prostate cancer. In other words, prostate cancer imaging is not “one-size-fits-all.”
In fact, the best imaging test for a person will depend on multiple factors, such as the PSA level, the Gleason score, and the kinds of treatment being considered.
Again, it depends. For most men, a diagnosis of prostate cancer requires a prostate biopsy.
When a prostate biopsy is being considered, MRI may be done before to help determine which part of the prostate gland needs to be biopsied. But MRI isn’t done before biopsy in every case.
It’s also important to note that, in some rare situations, biopsy may not be needed. For example, if a person has a bone scan showing obvious metastasis, and the PSA level is very high, biopsy isn’t needed to confirm metastatic prostate cancer.
After treatment of localized prostate cancer (usually with surgery or radiation therapy), your healthcare team will monitor you to be sure the cancer doesn’t come back.
In most cases, monitoring is done with regular PSA blood tests. If the PSA level goes down after treatment and never comes back up again, there’s usually no need for imaging. But if the PSA starts to go back up again, this means there’s active prostate cancer somewhere in the body. In this situation, imaging tests can help to find it.
Finally, if you received treatment for stage 4 (metastatic) cancer, imaging tests can monitor how you’re responding to treatment. The location of the metastases usually determines which tests will be used:
MRI of the pelvis (with IV contrast) can identify cancer in the soft tissues of the pelvis or in the lymph nodes.
Bone scan can identify metastatic cancer if it has spread to the bones.
Positron emission tomography (PET) is an imaging test that uses a radioactive tracer (given through an IV) to identify the location of a cancer anywhere in the body.
When your doctor orders an imaging test, you will probably get instructions on how to prepare for the tests. It’s important to follow those instructions. Here is a brief overview of things to know as you prepare for the different prostate cancer imaging tests.
MRI is safe for most people. But if you have metallic implants (like surgical screws or plates), it may not be safe to have an MRI scan. MRI may affect the function of some pacemakers, defibrillators, or other implanted devices. So if you have any metal or an implanted device in your body, be sure to ask your healthcare provider if it’s safe to get an MRI.
Additionally, MRI often involves the use of an IV contrast called gadolinium. Although this contrast is usually safe, some people can have allergic reactions to gadolinium. Be sure to let your provider know if you’ve had an allergy to contrast before. People with chronic kidney disease may also need to avoid gadolinium because it can damage their kidneys.
Finally, prostate MRI sometimes involves placement of an “endorectal coil.” This is a wire that’s placed in the rectum to improve the quality of the images. If an endorectal coil is used, your doctor may instruct you to use an enema to empty your rectum before the MRI scan.
Like MRI scans, some CT scans are done with IV contrast to make the images clearer. The most common IV contrast used for CT contains iodine. If you’re allergic to iodine, you should avoid IV contrast for CT scans.
Like gadolinium, iodine contrast can also cause problems in people who have kidney disease. So if you’re getting a CT scan with IV contrast, your doctor may order a blood test beforehand to make sure your kidneys are healthy.
If you’re getting a bone scan, there are no specific procedures that you need to follow before the scan. Eating and/or drinking will not affect the results of the scan.
Before getting a PET scan, you’ll be instructed not to eat or drink anything for several hours. Additionally, you may need a blood test before the scan to make sure that it will be accurate.
In particular, high or low blood sugar (glucose) affects the quality of some PET scans. To ensure a high-quality scan, providers often recommend checking a blood glucose level before the test.
Medications that change blood glucose levels can also affect PET scan results. You should tell your doctor about all medications that you’re taking. In some cases, your doctor might ask you to hold one or more of your medications before the scan.
Every case of prostate cancer is unique, and there’s no one-size-fits-all approach to its diagnosis, treatment, or monitoring.
Each of the imaging tests mentioned above is used to answer a specific question about an individual person’s prostate cancer. Not all imaging tests mentioned above will be used in every prostate cancer case.
If you have prostate cancer, it’s important to speak with your doctor about which tests might be useful in your case.
American Cancer Society. (2021). Key statistics for prostate cancer.
American Urologic Association. (2017). Clinically localized prostate cancer: AUA/ASTRO/SUO guideline.
Choosing Wisely. (2012). Imaging tests for early prostate cancer.
Coakley, F., et al. (2017). ACR appropriateness criteria prostate cancer - pretreatment detection, surveillance, and staging. Journal of the American College of Radiology.
Eklund, M., et al. (2021). MRI-targeted or standard biopsy in prostate cancer screening. New England Journal of Medicine.
Marcus, D. M., et al. (2014). The impact of multiparametric magnetic prostate imaging on risk stratification in patients with localized prostate cancer. Urology.
Mehraviland, S., et al. (2018). A magnetic resonance imaging-based prediction model for prostate biopsy risk stratification. JAMA Oncology.
National Cancer Institute. (2013). Tumor grade fact sheet.
National Cancer Institute. (2021). Prostate-specific antigen.
Prostate Cancer Foundation. What is a Gleason score?